Covidien Makes Deal With Watson To Allow Generic Exalgo
Zalicus Inc. on Wednesday said Covidien PLC, with which it partners on Covidien's painkiller Exalgo, has agreed to a settlement with Watson Pharmaceuticals Inc. that will allow a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article